Alere acquires Arriva Medical for $65 million, plus stock

12/2/2011 | Clinica (subscription required)

Arriva Medical, which supplies blood glucose monitors and other diabetes testing devices to patients' homes, has been acquired by in vitro diagnostics firm Alere for $65 million in cash, plus 806,452 restricted company shares. The deal will allow Alere to expand its footprint in the point-of-care diabetes diagnostics arena.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC